Biotech—it's complicated. A successful product launch requires grit, determination, and clear direction. But let’s be real, the path to launch isn’t a straight one. There are curves, hard turns, and dead ends. Here’s the good news, you don’t have to navigate the complexities alone. Welcome to The Emerging Biotech Leader, where we help biotech leaders maximize the value of their therapeutics from clinical development to product launch.
…
continue reading
Biotech Executive Podcasts
Welcome to the Proactive podcast channel – the destination for breaking news on growth companies and up to the minute market coverage. Here we plug you into what’s new and exciting in the world of business.
…
continue reading
Industry Ignited is a platform for bold conversations with leaders who are transforming the way business gets done. Each episode spotlights breakthrough stories from the industrial, manufacturing, biotech, chemical, and B2B sectors, giving you an inside look at how top executives, innovators, and changemakers tackle real-world challenges and drive meaningful growth. Hosted by Dr. Leeanne Aguilar—entrepreneur, executive coach, and marketing strategist—Industry Ignited goes beyond surface-leve ...
…
continue reading
Have you ever thought about who the people are behind life-saving breakthroughs? How did they get started in their careers? Why did they choose the Life Sciences? What effect do they hope to cause? These are the questions we explore on The Life Science Effect. Gain insights straight from thought leaders, entrepreneurial game-changers, and business executives leading the Life Sciences. Host Steve Vinson explores what it really takes to be effective in this industry as a leader and innovator w ...
…
continue reading
The Biotech Startups Podcast by Excedr features weekly conversations with founders, scientists, and investors driving biotech innovation. Host Jon Chee dives into the challenges of building biotech startups, from pre-seed to IPO. New episodes every Monday and Thursday.
…
continue reading
A podcast to share the tools, tips, tricks and routines of the best biotech executives in the industry in order to help develop the next generation of biotech leaders and expedite the launch of new therapies and transform the lives of patients' all over the world.
…
continue reading
Live Like a Leader Show — Where Great Leaders Master Great Communication L = f (c): Leadership is a function of Communication. Great leadership is a function of great communication. Join leadership communication expert, TEDx speaker, author, and executive coach John Bates, founder of Executive Speaking Success, as he explores the communication, leadership, and life secrets of the world’s top leaders. From NASA astronauts and bestselling authors to Navy SEALs, global executives, entrepreneurs ...
…
continue reading
STAT’s weekly biotech podcast, breaking down the latest news, digging deep into industry goings-on, and giving you a preview of the week to come.
…
continue reading
Russ Branzell, President & CEO of the College of Healthcare Information Management Executives (CHIME), interviews leaders in Digital Health from around the world. These thought leaders share their knowledge, challenges, best practices, and ideas for helping to transform health and care on a global level.
…
continue reading
CPO PLAYBOOK isn’t your typical business podcast. Hosted by Felicia Shakiba—Korn Ferry executive coach and fixer of high-stakes people problems—we tackle the stuff that keeps founders, investors, and execs up at night. From leadership blind spots to messy M&As, scaling headaches to culture chaos—we don’t just talk about business, we solve it. Guests? Think PepsiCo, SoftBank, Harvard, Reddit, Valentino, Adidas, Stanford, and MCM Capital—aka the folks shaping global markets and billion-dollar ...
…
continue reading
Growth Stories is a podcast about the innovations and trends driving the stock market’s next big winners. IBD multimedia reporter Alexis Garcia interviews analysts, executives, authors and influencers to take investors behind the latest innovations and trends driving growth in leading companies and sectors.
…
continue reading
Hosted by Glenn Hunzinger, US Health Industries Leader, the Next in Health podcast series offers insights on the most important issues facing pharma, medtech, and healthcare. PwC business leaders discuss the latest trends and their impact on health industries, whether it is policy, AI, innovation, care delivery, business model reinvention, or bold moves shaping the future. If it is happening in health industries, we are talking about it.
…
continue reading
Welcome to the Petauri PACT Executive Briefing, where in 3-minutes we highlight healthcare’s critical market access issues, policies, challenges, or trends. This resource offers condensed, 3-minute episodes of market insights. Our passion is on achieving the Quintuple Aim of enhancing patient experience, improving population health, reducing costs, improving the work life of health care providers and staff., and enhancing health equity in all aspects of care delivery. I’m Dr. Warren Smedley, ...
…
continue reading
Together with prominent Pharmaceutical industry leaders, Impetus Digital is covering topics around what it means to be an effective leader in Pharma today. We are also exploring topics related to digital transformation, patient-centricity, industry partnerships, customer engagement, diversity in Pharma, systems thinking, current healthcare challenges, environmental and supply chain concerns, and the myriad of ways that Pharma is working to collectively and positively disrupt healthcare. At I ...
…
continue reading
Tech Tomorrow is your front-row seat to the conversations redefining the future. Each episode explores one big question about data, AI, or emerging tech, giving leaders clear, focused answers they can trust. If you're navigating complex innovation, from AI-augmented delivery to sustainability, this show helps you cut through the noise, connect cross-disciplinary trends, and lead with confidence in a rapidly evolving landscape. Previously known as Data Today, this podcast has examined how out ...
…
continue reading
The Prospect Group is a leading global firm specializing in media, research, and consulting. We meet, and discuss the most relevant economic issues with, hundreds of the world’s leading business executives, political elites, and other influential personalities from a cross-section of industries and countries. Watch video interviews from and/or about Malaysia.
…
continue reading
Presented by Levi & Korsinsky, this is your go-to podcast for breaking down securities class action lawsuits in a way that’s clear, engaging, and easy to follow. Join hosts Anna and Nate—your curious guide and knowledgeable insider—as they explore the latest cases, spotlight key developments, and unpack what it all means for investors. Whether you’re a shareholder, active investor, or just intrigued by securities litigation, each episode offers sharp insights and straightforward analysis. Po ...
…
continue reading
The Global Innovators in Business discovers innovators who have challenged the status quo. We invite some of the most successful leaders to share their thoughts and advice to the younger generation.
…
continue reading
1
🧬 The "Respiration Model": Balancing Debate & Execution | Jacob Glanville Re-Release (Part 3/4)
34:03
34:03
Play later
Play later
Lists
Like
Liked
34:03🧬 The Biotech Startups Podcast is powered by Excedr—helping life science startups accelerate R&D and commercialization with founder-friendly equipment leasing. Skip the upfront costs, stay lean, and focus on breakthrough science. As a TBSP listener, you can get exclusive perks through Excedr’s partner network—special savings, promotions, and more. …
…
continue reading
1
Tonix highlights pathway for potential single-dose, seasonal protection against Lyme Disease
5:14
5:14
Play later
Play later
Lists
Like
Liked
5:14Tonix Pharmaceuticals Holdings CEO Dr. Seth Lederman joined Steve Darling from Proactive to share an update on the company’s TNX-4800 program, underscoring its potential to address a significant unmet need in the prevention of Lyme disease. TNX-4800 is a long-acting human monoclonal antibody designed to target outer surface protein A of Borrelia bu…
…
continue reading
1
American Resources secures $200M facility to scale ReElement’s U.S. critical minerals platform
4:35
4:35
Play later
Play later
Lists
Like
Liked
4:35American Resources Corp CEO Mark Jensen joined Steve Darling to announce that the company’s subsidiary, ReElement Technologies, has closed a $200 million strategic equity facility with Transition Equity Partners, LLC (TEP). The company said the significant investment is expected to accelerate the commercial deployment of ReElement’s proprietary, mu…
…
continue reading
1
OKYO Pharma appoints Ophthalmology veteran Robert Dempsey as new CEO
7:49
7:49
Play later
Play later
Lists
Like
Liked
7:49OKYO Pharma’s new CEO Robert Dempsey joined Steve Darling from Proactive to discuss the leadership transition and the company’s strategic direction. As part of the change, former CEO Gary Jacob, Ph.D., will assume the role of Chief Development Officer while continuing to serve on OKYO’s Board of Directors, ensuring continuity across leadership and …
…
continue reading
1
🧬 No Margin, No Mission: The Business Truth Healthcare Leaders Must Accept | Amy Hay (Part 1/4)
33:44
33:44
Play later
Play later
Lists
Like
Liked
33:44🧬 The Biotech Startups Podcast is powered by Excedr—helping life science startups accelerate R&D and commercialization with founder-friendly equipment leasing. Skip the upfront costs, stay lean, and focus on breakthrough science. As a TBSP listener, you can get exclusive perks through Excedr’s partner network—special savings, promotions, and more. …
…
continue reading
1
🧬 From Vendor to Trusted Advisor: A New B2B Playbook in Biotech | Jason C. Foster Re-Release (2/2)
1:03:30
1:03:30
Play later
Play later
Lists
Like
Liked
1:03:30🧬 The Biotech Startups Podcast is powered by Excedr—helping life science startups accelerate R&D and commercialization with founder-friendly equipment leasing. Skip the upfront costs, stay lean, and focus on breakthrough science. As a TBSP listener, you can get exclusive perks through Excedr’s partner network—special savings, promotions, and more. …
…
continue reading
1
Why The Next Big AI Concern Runs Through Main Street
28:17
28:17
Play later
Play later
Lists
Like
Liked
28:17Data centers are increasingly at the center of local political battles as rising energy costs and environmental concerns fuel community frustration. IBD reports on how rising opposition threatens to squeeze the margins of Big Tech's biggest players. Learn more about your ad choices. Visit megaphone.fm/adchoices…
…
continue reading
1
🧬 People Aren’t Rational: Why That’s an Advantage as a Leader | Jason C. Foster Re-Release (1/2)
55:50
55:50
Play later
Play later
Lists
Like
Liked
55:50🧬 The Biotech Startups Podcast is powered by Excedr—helping life science startups accelerate R&D and commercialization with founder-friendly equipment leasing. Skip the upfront costs, stay lean, and focus on breakthrough science. As a TBSP listener, you can get exclusive perks through Excedr’s partner network—special savings, promotions, and more. …
…
continue reading
1
Turning Niche Crops Into Profitable Systems: Andrew Bish of BISH Enterprises & Hemp Harvest Works | Ep. 53
35:55
35:55
Play later
Play later
Lists
Like
Liked
35:55In this Industry Ignited episode, Dr. Leeanne Aguilar talks with Andrew Bish, CEO of BISH Enterprises and Hemp Harvest Works (Giltner, Nebraska) and President of the Hemp Feed Coalition, about what it takes to modernize agriculture when the barriers aren’t just engineering—they’re markets, policy, and perception. Andrew shares how returning to his …
…
continue reading
1
🧬 Choosing the Right VC: What Money Can’t Buy | Jacob Glanville Re-Release (Part 4/4)
30:31
30:31
Play later
Play later
Lists
Like
Liked
30:31🧬 The Biotech Startups Podcast is powered by Excedr—helping life science startups accelerate R&D and commercialization with founder-friendly equipment leasing. Skip the upfront costs, stay lean, and focus on breakthrough science. As a TBSP listener, you can get exclusive perks through Excedr’s partner network—special savings, promotions, and more. …
…
continue reading
1
Avalon GloboCare director unveils RPM AI studio
7:04
7:04
Play later
Play later
Lists
Like
Liked
7:04Avalon GloboCare Corp (NASDAQ:ALBT) director Michael Mathews talked with Proactive's Stephen Gunnion about the development of RPM’s innovative AI video production platform, Catch-Up. Mathews, who also serves as CEO of RPM, described the platform as the first of its kind - capable of producing videos automatically using generative AI and large langu…
…
continue reading
1
Tonix licenses global rights to novel non-opioid neuropathic pain drug TNX-4900
4:20
4:20
Play later
Play later
Lists
Like
Liked
4:20Tonix Pharmaceuticals Holdings CEO Dr. Seth Lederman joined Steve Darling from Proactive to announce that the company has secured exclusive worldwide licensing rights to TNX-4900, a highly selective small-molecule Sigma-1 receptor (S1R) antagonist with demonstrated analgesic activity across multiple preclinical models of neuropathic pain.Lederman e…
…
continue reading
1
Arrow Exploration brings Mateguafa HZ7 well online, delivers strong initial production in Colombia
4:13
4:13
Play later
Play later
Lists
Like
Liked
4:13Arrow Exploration CEO Marshall Abbott joined Steve Darling from Proactive to provide an operational update on activity at the Mateguafa Attic field, located on the Tapir Block in Colombia’s prolific Llanos Basin, where Arrow holds a 50% beneficial interest. The update highlighted the successful drilling, completion, and initial production performan…
…
continue reading
1
U.S. Gold raises $31.2M in private placement to advance CK gold project
4:40
4:40
Play later
Play later
Lists
Like
Liked
4:40U.S. Gold Corp. Chairman Luke Norman joined Steve Darling from Proactive to provide an update on the company’s financing activities following the successful closing of a private placement that raised approximately $31.2 million in gross proceeds. The financing represents a significant step forward as the company advances toward development of its f…
…
continue reading
1
GMG secures EPA approval milestone for THERMAL-XR® ENHANCE as US commercialisation advances
5:58
5:58
Play later
Play later
Lists
Like
Liked
5:58Graphene Manufacturing Group CEO Craig Nicol joined Steve Darling from Proactive to provide an update on the company’s commercialisation progress, highlighting a major regulatory milestone for its THERMAL-XR® ENHANCE graphene coating product. GMG announced it has received and accepted the United States Environmental Protection Agency’s consent noti…
…
continue reading
1
Medicus Pharma partners With Reliant AI to advance AI-driven clinical trial analytics
4:19
4:19
Play later
Play later
Lists
Like
Liked
4:19Medicus Pharma Chief Medical Officer Dr. Faisel Mehmud joined Steve Darling from Proactive to announce that the company has entered into a non-binding letter of intent with Reliant AI, a decision-intelligence company specializing in generative artificial intelligence for the life sciences. The proposed collaboration is focused on developing an AI-p…
…
continue reading
1
Nextech3D.ai confirms Krafty Labs acquisition aet to close in early January
5:21
5:21
Play later
Play later
Lists
Like
Liked
5:21Nextech3D.ai CEO Evan Gappelberg joined Steve Darling from Proactive to announce that the company has successfully completed its due diligence process and is preparing to close its acquisition of Krafty Labs on January 2, 2026, subject to customary closing conditions, including approval from the Canadian Securities Exchange (CSE).Gappelberg explain…
…
continue reading
1
Helix eyes first helium output at Rudyard with PSA unit set to arrive
2:32
2:32
Play later
Play later
Lists
Like
Liked
2:32HeLIX Exploration PLC (AIM:HEX, OTCQB:HHEXF) CEO Bo Sears talked with Proactive's Stephen Gunnion about the company’s imminent transition into helium production at its Rudyard project in Montana. Sears confirmed that the PSA compressor, described as the "long lead item," is now en route to site, marking the final step in completing the processing u…
…
continue reading
1
Confessions of a Hacker with Jeremiah Baker
50:14
50:14
Play later
Play later
Lists
Like
Liked
50:14In this episode, we cover: ✅ How Jeremiah went from bootstrapping websites during the dot-com boom to building a global cybersecurity business. ✅ Why most cybercrime isn’t about “hacking systems,” it’s about hacking humans. ✅ The emotional tricks scammers use, and how to spot them before you get duped. ✅ Real-world stories of cybercrime that cost c…
…
continue reading
1
Oakmount & Partners investee Intergroup Mining moves closer to Nasdaq IPO with SEC filing
5:52
5:52
Play later
Play later
Lists
Like
Liked
5:52Oakmount & Partners Ltd managing director Glenn King talked with Proactive's Stephen Gunnion about the progress investee company Intergroup Mining has made toward its planned listing on the Nasdaq stock exchange.King explained that the submission of legal and accounting documentation to the US Securities and Exchange Commission (SEC) marks a “signi…
…
continue reading
1
Frontier IP investee Dekiln secures £3m for low-carbon tile tech scale-up
2:59
2:59
Play later
Play later
Lists
Like
Liked
2:59Dekiln CEO Dr Aled Roberts talked with Proactive's Stephen Gunnion about the company’s breakthrough in sustainable ceramic tile production and how £3 million in funding from the Royal Academy of Engineering’s Green Future Fellowship program will help scale the technology.Roberts explained that conventional ceramic tiles have a high carbon footprint…
…
continue reading
1
Reinventing Footwear Manufacturing in India: Chandan Manocha, CEO of Player Footwear | Ep. 52
26:14
26:14
Play later
Play later
Lists
Like
Liked
26:14In this Industry Ignited episode, Dr. Leeanne Aguilar sits down with Chandan Manocha, CEO of Player Footwear Company in Delhi, India, to explore how a third-generation manufacturer can be modernized through science, design thinking, and customer-first innovation. Taking over the business at just 19 during COVID, Chandan used the shutdown as a reset…
…
continue reading
1
Deals Outlook 2026: What’s ahead for pharma and life sciences
11:14
11:14
Play later
Play later
Lists
Like
Liked
11:14Tune in as Glenn Hunzinger and Roel van den Akker share their outlook for pharmaceutical and life sciences dealmaking in 2026. They discuss improving market conditions, innovation driven growth, and how upcoming loss of exclusivity is shaping deal strategy. Discussion highlights: Strong innovation, healthy balance sheets, and improving capital mark…
…
continue reading
1
Deals Outlook 2026: What’s ahead for health services
8:57
8:57
Play later
Play later
Lists
Like
Liked
8:57Join Glenn Hunzinger and Dan Farrell as they discuss why 2026 could mark a rebound year for health services dealmaking—driven by higher-quality assets, improving market conditions, and the growing role of technology and AI. They explore how investors are rethinking value creation, from tech-enabled care models to carve-outs and IPOs. Discussion hig…
…
continue reading
1
M2i Global advances Volato merger and updates exclusive offtake with Next-Gen
3:49
3:49
Play later
Play later
Lists
Like
Liked
3:49M2i Global CEO Alberto Rosende joined Steve Darling from Proactive to provide an update on the company’s strategic initiatives, including progress on its merger with Volato and a new offtake agreement with Next-Gen.Rosende confirmed that the long-anticipated merger with Volato is moving forward after delays caused by a recent government shutdown. “…
…
continue reading
1
Replenish Nutrients moves into commercialization with major U.S. licensing deal
5:08
5:08
Play later
Play later
Lists
Like
Liked
5:08Replenish Nutrients CEO Neil Wiens joined Steve Darling to outline the company’s transition from development into full commercialization, highlighted by strategic licensing agreements and a significant partnership in the United States.Wiens described 2025 as a pivotal transformation year for Replenish Nutrients. During this period, the company succ…
…
continue reading
1
ProPhase Labs announces LOI for reverse merger with Advanced Biological
5:59
5:59
Play later
Play later
Lists
Like
Liked
5:59ProPhase Labs CEO Ted Karkus joined Steve Darling from Proactive to announce that the company has entered into a non-binding Letter of Intent (LOI) regarding a proposed reverse merger transaction with Advanced Biological Laboratories (ABL), a European biotechnology and MedTech group. Under the proposed structure, Advanced Biological would become th…
…
continue reading
1
Cabbacis prepares for U.S. launch of low-nicotine iBlend products
5:09
5:09
Play later
Play later
Lists
Like
Liked
5:09Cabbacis CEO Joe Pandolfino joined Steve Darling from to discuss the company’s strategic preparations to enter the U.S. market with its proprietary low-nicotine tobacco products. Cabbacis is a federally licensed tobacco product manufacturer with a robust intellectual property portfolio that includes 35 issued patents worldwide, covering its iBlend™…
…
continue reading
1
How Fractional Executive Teams Are Changing Life Sciences: Richard Rives Bird of Rives Consult | Ep. 51
38:18
38:18
Play later
Play later
Lists
Like
Liked
38:18In this Industry Ignited episode, Dr. Leeanne Aguilar interviews Richard Rives Bird, President of Rives Consult, on why breakthrough medical devices don’t succeed on innovation alone—they succeed when founders pair great science with the right commercialization strategy, regulatory pathway, and reimbursement reality. Richard shares how he moved fro…
…
continue reading
We’re excited to announce that Tech Tomorrow will be extending Season 3 into early 2026. Join host David Elliman for more insightful conversations designed to help you navigate the complex world of emerging technology and make more informed decisions as a leader and decision-maker. You can expect deep dives into topics like AI, cybersecurity, and m…
…
continue reading
1
Happy Creek reports strong Tungsten assays from 2025 drilling at Fox project
3:42
3:42
Play later
Play later
Lists
Like
Liked
3:42Happy Creek Minerals CEO Steve Gray joined Steve Darling from Proactive to share details of the company’s latest assay results from its 2025 diamond drilling program at the Fox Tungsten Project in British Columbia. The recently completed program focused on expanding the known tungsten mineralization at the Ridley Creek (RC) and BN zones, two of the…
…
continue reading
Is the biotech industry truly out of its slump? Why are employers dropping coverage of weight loss drugs? And what will the hosts bake for the holidays? We discuss all that and more on this week's episode of "The Readout LOUD," the last episode of the year. We bring on Bruce Booth, partner at venture capital firm Atlas Venture, to reflect on everyt…
…
continue reading
1
Ilika begins shipping Stereax M300 prototypes, reaching key commercial milestone
3:40
3:40
Play later
Play later
Lists
Like
Liked
3:40Ilika CEO Graeme Purdy joined Steve Darling from Proactive to announce that the company has begun shipping prototype Stereax M300 solid-state batteries to customers, marking a significant commercial milestone for the business. The initial shipments represent the first delivery of the M300 product and will be allocated to the 21 customers that curre…
…
continue reading
1
🧬 From Raw Data to Better Drugs: Deep Sequencing Antibodies | Jake Glanville Re-Release (2/4)
30:54
30:54
Play later
Play later
Lists
Like
Liked
30:54🧬 The Biotech Startups Podcast is powered by Excedr—helping life science startups accelerate R&D and commercialization with founder-friendly equipment leasing. Skip the upfront costs, stay lean, and focus on breakthrough science. As a TBSP listener, you can get exclusive perks through Excedr’s partner network—special savings, promotions, and more. …
…
continue reading
1
Skyler Weinand on rate cuts and bond strategies
7:35
7:35
Play later
Play later
Lists
Like
Liked
7:35Regan Capital CIO Skyler Weinand joined Steve Darling from Proactive to share news about the dynamics of the fixed income markets, interest rates, and mortgage-backed securities.Weinand outlined Regan Capital’s focus on U.S. mortgage-backed securities, noting the company manages around $3.6 billion across mutual funds, ETFs, and a UCITS ETF for non…
…
continue reading
1
Standard Uranium maps 2026 growth after strong funding and JV progress in 2025
6:40
6:40
Play later
Play later
Lists
Like
Liked
6:40Standard Uranium CEO Jon Bey joined Steve Darling from Proactive to discuss the company’s operational progress throughout 2025 and outline its strategic roadmap heading into 2026, highlighting a year marked by successful capital raising, advancing exploration programs, and the expansion of its joint venture portfolio.Bey noted that Standard Uranium…
…
continue reading
1
1911 Gold launches 2,200 metre drill program at Ogama-Rockland gold deposit
4:48
4:48
Play later
Play later
Lists
Like
Liked
4:481911 Gold Corporation Chairman Gary O’Connor joined Steve Darling from Proactive to announce the start of a 2,200-metre diamond drilling program at the Ogama-Rockland gold deposit, located southeast of the company’s True North Gold Project.The program has already commenced, with one surface diamond drill rig mobilized to site. The drilling campaign…
…
continue reading
1
BioVie advances Parkinson’s, long COVID, and liver disease programs ahead of 2026
5:35
5:35
Play later
Play later
Lists
Like
Liked
5:35BioVie CEO Cuong Do joined Steve Darling from Proactive to provide an update on the company’s recent progress across its two lead drug candidates, Bezisterim and BIV201, as BioVie positions itself for multiple clinical and regulatory catalysts in 2026.Bezisterim, an anti-inflammatory compound that blocks tumor necrosis factor alpha (TNF-α), is bein…
…
continue reading
1
2025.12.17 Tiziana Life Tiziana Life Sciences doses first patient in Phase 2 Alzheimer’s clinical trial Ltd
5:14
5:14
Play later
Play later
Lists
Like
Liked
5:14Tiziana Life Sciences CEO Ivor Elrifi joined Steve Darling from Proactive to announce a key clinical milestone, confirming that the first patient has been successfully dosed with intranasal foralumab in the company’s Phase 2 randomized, placebo-controlled clinical trial in patients with early Alzheimer’s disease (AD).This achievement follows the co…
…
continue reading
1
What Does It Take to Build a Gigawatt of Solar in Texas? Sol Bobst, Solar Ranch Development Company | Ep. 50
29:21
29:21
Play later
Play later
Lists
Like
Liked
29:21In this episode of Industry Ignited, Dr. Leeanne Aguilar sits down with Sol Bobst, President of Solar Ranch Development Company and ToxSci Advisors, to explore how Texas can meet a rapidly accelerating power demand through practical, scalable renewable energy development. Sol shares how his background as a board-certified toxicologist and applied s…
…
continue reading
1
Allergy Therapeutics CEO on grass vaccine milestone and next steps
7:36
7:36
Play later
Play later
Lists
Like
Liked
7:36Allergy Therapeutics PLC (AIM:AGY, OTC:AGYTF) chief executive Manuel Llobet talked with Proactive's Stephen Gunnion about the granting of approval for Grassmuno, its grass allergy immunotherapy vaccine, in Germany - a significant milestone for the company.Llobet explained that the product is the first to be approved under the Therapieallergene-Vero…
…
continue reading
1
EnWave reports strong Q4 and FY2025 results as machine sales and royalties grow
3:37
3:37
Play later
Play later
Lists
Like
Liked
3:37EnWave Corporation CEO Brent Charleton joined Steve Darling from Proactive to discuss the company’s interim financial results for the fourth quarter and fiscal year ended September 30, 2025, highlighting a strong finish to the year driven by rising machine sales and expanding royalty streams.For the fourth quarter of fiscal 2025, EnWave reported re…
…
continue reading
1
Nextech3D.ai strengthens sales leadership to drive commercial growth in 2026
8:23
8:23
Play later
Play later
Lists
Like
Liked
8:23Nextech3D.ai CEO Evan Gappelberg and the company’s newly appointed Global Head of Sales, James McGuinness, joined Steve Darling from Proactive to discuss the strategic importance of McGuinness’ appointment as the company sharpens its focus on expanding commercial operations heading into 2026.Gappelberg explained that strengthening the sales organiz…
…
continue reading
1
Medicus Pharma completes enrollment in Phase 2 skin cancer microneedle study
5:49
5:49
Play later
Play later
Lists
Like
Liked
5:49Medicus Pharma CEO Dr Raza Bokhari joined Steve Darling from Proactive to announce another major clinical milestone for the company, confirming that enrollment has been successfully completed in its Phase 2 clinical study evaluating the safety and efficacy of its Doxorubicin Microneedle Array (D-MNA), also known as SKNJCT-003, for the non-invasive …
…
continue reading
1
C3 Metals hits broad copper mineralization in first-ever drill hole at Khaleesi
5:18
5:18
Play later
Play later
Lists
Like
Liked
5:18C3 Metals CEO Dan Symons joined Steve Darling from Proactive to announce highly encouraging results from the first drill hole ever completed at the company’s Khaleesi copper project in southern Peru, marking a significant milestone for the greenfield exploration asset.The inaugural hole returned a broad intercept of 269.0 metres grading 0.30% coppe…
…
continue reading
1
Blue Gold secures $4.5B gold supply to launch tokenized gold strategy
9:15
9:15
Play later
Play later
Lists
Like
Liked
9:15Blue Gold Limited CEO Andrew Cavaghan joined Steve Darling from Proactive to outline the company’s latest strategic initiatives, highlighted by a major move into the rapidly emerging tokenized gold market.Cavaghan confirmed that Blue Gold Ltd has signed a landmark agreement securing access to 1 million ounces of gold, with an estimated value of app…
…
continue reading
1
Beyond the Buzz: Reimagining Cloud and Data Strategies in Healthcare
25:48
25:48
Play later
Play later
Lists
Like
Liked
25:48What Keeps You Up at Night? – Tales from the Digital Frontier Russ Branzell, President and CEO of CHIME, sits down with Tim Lankes, Vice President of Healthcare at Rackspace, for a candid conversation on the realities behind cloud modernization in healthcare. Drawing on decades of experience leading large-scale healthcare technology and services in…
…
continue reading
1
Pathos CEO Omar Hamdi on IPO, AI tech & growth strategy
8:08
8:08
Play later
Play later
Lists
Like
Liked
8:08Pathos Communications (LSE:NEWS) CEO Omar Hamdi talked with Proactive's Stephen Gunnion about the company’s mission to revolutionise media access for small and medium-sized enterprises (SMEs) through its proprietary AI tools.Hamdi outlined how Pathos Communications solves a long-standing issue in the PR space: getting SMEs into mainstream media cov…
…
continue reading
1
Genflow Biosciences CEO discusses next steps as canine gene therapy trial hits milestone
6:47
6:47
Play later
Play later
Lists
Like
Liked
6:47Genflow Biosciences Ltd (LSE:GENF, OTCQB:GENFF) CEO Dr Eric Leire talked with Proactive's Stephen Gunnion about the company’s progress in its canine gene therapy trial targeting sarcopenia.Leire confirmed that the dosing phase has now been completed with no adverse effects, calling it a key milestone in de-risking the SIRT6 programme for potential …
…
continue reading